EVG.L Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (24 apr 2024 @ 17:24):

Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases...

Stats
Dagens volum	10.75M
Gjennomsnittsvolum	1.25M
Markedsverdi	3.42M
EPS	£0 ( 2024-04-19 )
Last Dividend	£0 ( N/A )
Next Dividend	£0 ( N/A )
P/E	-0.800
ATR14	£0 (0.00%)

Evgen Pharma PLC Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Evgen Pharma PLC Økonomi

Annual	2022
Omsetning:	£442 000
Bruttogevinst:	£429 000 (97.06 %)
EPS:	£-0.0147

FY	2022
Omsetning:	£442 000
Bruttogevinst:	£429 000 (97.06 %)
EPS:	£-0.0147

FY	2022
Omsetning:	£0
Bruttogevinst:	£0 (0.00 %)
EPS:	£-0.00990

FY	2021
Omsetning:	£194 000
Bruttogevinst:	£0.00 (0.00 %)
EPS:	£-0.0279

Financial Reports:

No articles found.

Evgen Pharma PLC

Evgen Pharma plc, a clinical stage drug development company, focuses on the development of sulforaphane-based medicines for the treatment of cancer and inflammatory diseases. It develops its products using Sulforadex, a sulforaphane stabilization technology. The company's lead product is SFX-01, that is in Phase II clinical trials for the treatment of metastatic breast cancer; and in Phase Ib/IIa clinical trials for the treatment of glioblastoma, as well as in preclinical stage for the treatment of haematological malignancies and analogues. It also provides out-licensing of its technology services. Evgen Pharma plc was incorporated in 2014 and is headquartered in Nether Alderley, the United Kingdom.